MSH|^~\&|EQUATORDXTRAY^EQUATORDXTRAY:0.12.8 (Build 310)^L|Demo Server^1FFA8984-7166-4655-B195-7B4FFFD2F136^GUID|||20050417213103+1000||ORU^R01|20050417.736380|P|2.3.1^AUS&&ISO^0.9&&L|||AL||AUS
PID|1||2345756^^^Medical-Objects&7C3E3682-91F6-11D2-8F2C-444553540000&GUID^SR^Buderim GE Centre&7C3E3681-91F6-11D2-8F2C-444553540000&GUID~4024728674^^^AUSHIC^MC~12345^^^Rx Medical^SR^Buderim GE Centre&7C3E3681-91F6-11D2-8F2C-444553540000&GUID~100004^^^Medical-Objects&7C3E3682-91F6-11D2-8F2C-444553540000&GUID^SR^Demo Server&1FFA8984-7166-4655-B195-7B4FFFD2F136&GUID||JONES^June^^^^^L||19760108|F|||24 Sutherland Street^^BUDERIM^QLD^4556^AUS^C|||54455531^PRN^PH^^^^54455531
PV1|1|O||||||0341616X^WHITE^WILSON^^^DR^^^AUSHICPR^L^^^UPIN|0191322W^ANDERSON^THOMAS^^^DR^^^AUSHICPR^L^^^UPIN
ORC|RE||04-4154148-25T-0^QML^2184^AUSNATA||CM|||||||0341616X^WHITE^WILSON^^^DR^^^AUSHICPR^L^^^UPIN
OBR|1||04-4154148-25T-0^QML^2184^AUSNATA|25T^E/LFT (MASTER)^2184|||200412220745+1000||||||||SER&Serum Random&HL7-70|0341616X^WHITE^WILSON^^^DR^^^AUSHICPR^L^^^UPIN||From Buderim GE Centre in File  dated 16.04.2005||DR=MME,LN=04-4154148,RC=Y||200502231004+1000||CH|F||^^^200412210000+1000|0341616X^WHITE^WILSON^^^DR^^^AUSHICPR^L^^^UPIN~0191322W^ANDERSON^THOMAS^^^DR^^^AUSHICPR^L^^^UPIN||||Dr Marcus Welby
OBX|1|ST|15430-2^^LN||SERUM CHEMISTRY||||||F
OBX|2|NM|2951-2^Sodium^LN^104934005^^SNOMED-CT||142|mmol/L^^ISO+|137-147||||F
OBX|3|NM|2823-3^Serum Potassium^LN^59573005^^SNOMED-CT||4.0|mmol/L^^ISO+|3.5-5.0||||F
OBX|4|NM|2075-0^Chloride^LN^46511006^^SNOMED-CT||107|mmol/L^^ISO+|96-109||||F
OBX|5|NM|1963-8^Bicarbonate^LN^88645003^^SNOMED-CT||26|mmol/L^^ISO+|25-33||||F
OBX|6|NM|1863-0^Other Anions^LN^271057005^^SNOMED-CT||13|mmol/L^^ISO+|4-17||||F
OBX|7|NM|14749-6^Glucose^LN^36048009^^SNOMED-CT||6.3|mmol/L^^ISO+|3.0-7.7||||F
OBX|8|NM|14937-7^Urea^LN^273967009^^SNOMED-CT||6.7|mmol/L^^ISO+|2.0-7.0||||F
OBX|9|NM|14682-9^Serum Creatinine^LN^70901006^^SNOMED-CT||0.08|mmol/L^^ISO+|0.04-0.11||||F
OBX|10|NM|14933-6^Serum Uric Acid^LN^86228006^^SNOMED-CT||0.40|mmol/L^^ISO+|0.14-0.35|++|||F
OBX|11|NM|14631-6^Total Bilirubin^LN^27171005^^SNOMED-CT||9|umol/L^^ISO+|2-20||||F
OBX|12|NM|14629-0^Direct Bilirubin^LN^39748002^^SNOMED-CT||4|umol/L^^ISO+|0-8||||F
OBX|13|NM|6768-6^Total Alk. Phosphatase^LN^88810008^^SNOMED-CT||144|U/L^^ISO+|30-115|+|||F
OBX|14|NM|2324-2^Gamma G.T.^LN^69480007^^SNOMED-CT||106|U/L^^ISO+|0-45|+++|||F
OBX|15|NM|1742-6^ALT^LN^34608000^^SNOMED-CT||30|U/L^^ISO+|0-45||||F
OBX|16|NM|1920-8^AST^LN^45896001^^SNOMED-CT||18|U/L^^ISO+|0-41||||F
OBX|17|NM|2532-0^LD^LN^11274001^^SNOMED-CT||143|U/L^^ISO+|80-250||||F
OBX|18|NM|2000-8^Serum Calcium^LN^71878006^^SNOMED-CT||2.28|mmol/L^^ISO+|2.25-2.65||||F
OBX|19|NM|13959-2^Corrected Calcium^LN^166708003^^SNOMED-CT||2.32|mmol/L^^ISO+|2.25-2.65||||F
OBX|20|NM|14879-1^Serum Phosphate^LN^104866001^^SNOMED-CT||1.3|mmol/L^^ISO+|0.8-1.5||||F
OBX|21|NM|2885-2^Total Protein^LN^74040009^^SNOMED-CT||66|g/L^^ISO+|60-82||||F
OBX|22|NM|1751-7^Serum Albumin^LN^104485008^^SNOMED-CT||41|g/L^^ISO+|35-50||||F
OBX|23|NM|10834-0^Globulins^LN^104979009^^SNOMED-CT||25|g/L^^ISO+|20-40||||F
OBX|24|NM|14798-3^Iron^LN^42950004^^SNOMED-CT||3|umol/L^^ISO+|10-33|---|||F
OBX|25|NM|14647-2^Cholesterol^LN^77068002^^SNOMED-CT||4.0|mmol/L^^ISO+|3.6-6.7||||F
OBX|26|FT|15415-3^^LN||Revised NHF cholesterol guidelines (Nov.,2001):\.br\  Target below 4.0 mmol/L if high risk patient.\.br\  Consider lipid lowering treatment if cholesterol above 6.0 mmol/L\.br\  and no other risk factor of CHD.\.br\||||||F
OBX|27|NM|14927-8^Triglycerides^LN^104784006^^SNOMED-CT||1.0|mmol/L^^ISO+|0.3-4.0||||F
OBX|28|FT|PIT^^AUSPDI||001 Medical-Objects                                            07 01/07/1996\.br\002   \.br\003 Report Run Number: 1    Created:   19/04/2005     at    22:58:15\.br\004 Surgery: XXX    Reports: 23/02/2005 10:04:00  to  23/02/2005 10:04:00       \.br\009 ---------------------------------------------------------------------------\.br\010 ANDERSON,DR. THOMAS                          0191322W\.br\019 ---------------------------------------------------------------------------\.br\020 Your Ref.   Patient Name                   Lab Ref.       Test\.br\021             JONES,June                      04-4154148     E/LFT (MASTER)\.br\029 ---------------------------------------------------------------------------\.br\100 Start Patient  :      JONES,June                      \.br\101                       24 Sutherland Street, BUDERIM QLD 4556               \.br\104                       Birthdate: 08/01/1976     Age: Y29     Sex:F\.br\105                       Telephone: 07              \.br\109   \.br\110 Your Reference :      \.br\111 MO  Reference  :      04-4154148-25T-0\.br\112 Medicare Number:                \.br\115 Phone Enquiries:       (DR MARCUS WELBY)                           \.br\119   \.br\121 Referred by    :      WHITE,DR. WILSON                \.br\122 Copy to        :      ANDERSON,DR. THOMAS             \.br\123 Addressee      :      ANDERSON,DR. THOMAS               0191322W\.br\129   \.br\200 Start of Result:\.br\201 Specimen       :\.br\203 Requested      :      21/12/2004\.br\204 Collected      :      22/12/2004  07:45\.br\205 Name of Test   :      E/LFT (MASTER)                                       \.br\206 Reported       :      23/02/2005  10:04\.br\207 Confidential   :      N\.br\208 Test Category  :      N\.br\209   \.br\210 Normal Result  :      N\.br\299   \.br\301                               Units  Ref Range\.br\301 \.br\301   SERUM CHEMISTRY\.br\301 Sodium                 142     mmol/L 137-147\.br\301 Serum Potassium        4.0     mmol/L 3.5-5.0\.br\301 Chloride               107     mmol/L 96-109\.br\301 Bicarbonate            26      mmol/L 25-33\.br\301 Other Anions           13      mmol/L 4-17\.br\301 Glucose                6.3     mmol/L 3.0-7.7\.br\301 Urea                   6.7     mmol/L 2.0-7.0\.br\301 Serum Creatinine       0.08    mmol/L 0.04-0.11\.br\301 \R\FG04\R\Serum Uric Acid        0.40 ++ mmol/L 0.14-0.35\R\FG99\R\\.br\301 Total Bilirubin        9       umol/L 2-20\.br\301 Direct Bilirubin       4       umol/L 0-8\.br\301 \R\FG04\R\Total Alk. Phosphatase 144 +   U/L    30-115\R\FG99\R\\.br\301 \R\FG04\R\Gamma G.T.             106 +++ U/L    0-45\R\FG99\R\\.br\301 ALT                    30      U/L    0-45\.br\301 AST                    18      U/L    0-41\.br\301 LD                     143     U/L    80-250\.br\301 Serum Calcium          2.28    mmol/L 2.25-2.65\.br\301 Corrected Calcium      2.32    mmol/L 2.25-2.65\.br\301 Serum Phosphate        1.3     mmol/L 0.8-1.5\.br\301 Total Protein          66      g/L    60-82\.br\301 Serum Albumin          41      g/L    35-50\.br\301 Globulins              25      g/L    20-40\.br\301 \R\FG04\R\Iron                   3 ---   umol/L 10-33\R\FG99\R\\.br\301 Cholesterol            4.0     mmol/L 3.6-6.7\.br\301 \.br\301 Revised NHF cholesterol guidelines (Nov.,2001):\.br\301   Target below 4.0 mmol/L if high risk patient.\.br\301   Consider lipid lowering treatment if cholesterol above 6.0 mmol/L\.br\301   and no other risk factor of CHD.\.br\301 \.br\301 Triglycerides          1.0     mmol/L 0.3-4.0\.br\309   \.br\319   \.br\390 End of Report  :\.br\399 ---------------------------------------------------------------------------\.br\999 END OF LISTING - Run Number:1     19/04/2005  22:58:15\.br\||||||F